Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
1:01:37
1:01:37
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:37
Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To …
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
1:00:13
1:00:13
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:00:13
Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
1:19:45
1:19:45
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:19:45
Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy, moderated by Dr Neil Love. Produced by Research To Practice. CME information and sel…
…
continue reading
1
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
1:01:41
1:01:41
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:41
Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers. CME informat…
…
continue reading
1
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
1:02:49
1:02:49
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:02:49
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
1:05:37
1:05:37
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:05:37
Dr Ian E Krop from the Yale Cancer Center in New Haven, Connecticut, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss patient cases and treatment strategies for HER2-positive and triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publi…
…
continue reading
1
Virtual Case Library: Metastatic Urothelial Bladder Cancer
2:08:14
2:08:14
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
2:08:14
Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer, moderat…
…
continue reading
1
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
37:32
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York City discusses available and emerging data with oral SERDs for patients with ER-positive metastatic breast cancer. CME information and select publications here.Research To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
1:00:04
1:00:04
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:00:04
Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
1:02:36
1:02:36
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:02:36
Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publicat…
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
58:01
Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
1:00:25
1:00:25
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:00:25
Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers, moderated by Dr Neil Love. Produced by Research To P…
…
continue reading
Dr Bradley J Monk from the Florida Cancer Specialists & Research Institute in West Palm Beach, Florida, discusses real-world patient cases and treatment strategies for ovarian cancer. CME information and select publications here.Research To Practice
…
continue reading
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
1:04:44
1:04:44
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:04:44
Dr Stephanie L Graff from the Legorreta Cancer Center at Brown University in Providence, Rhode Island, and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston discuss treatment decision-making involving approved and investigational strategies for the management of hormone receptor-positive breast cancer. CME information and select publicatio…
…
continue reading
1
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
1:01:29
1:01:29
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:29
Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
1:00:18
1:00:18
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:00:18
Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
1:05:28
1:05:28
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:05:28
Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers. CME information and select publications here.Research To Practice
…
continue reading
1
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
1:00:17
1:00:17
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:00:17
Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
1:30:16
1:30:16
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:30:16
Dr Luis Paz-Ares from the National Oncology Research Center in Madrid, Spain, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, and Dr David R Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss key presentations from the 2023 ESMO Congress for the management of lung cancer, moderated by Neil Love. Prod…
…
continue reading
1
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
1:01:54
1:01:54
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:54
Featuring a discussion on optimizing the management of gastroesophageal cancers with Dr Samuel J Klempner, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice
…
continue reading
1
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
1:03:00
1:03:00
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:03:00
Dr Aditya Bardia from Massachusetts General Hospital and Dr Sara M Tolaney from the Dana-Farber Cancer Institute, both in Boston, Massachusetts, discuss key presentations on the management of breast cancer from the 2023 ESMO Congress, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
1
Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
1:01:30
1:01:30
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:30
Dr Richard Penson from Massachusetts General Hospital in Boston, Massachusetts and Dr Krishnansu Tewari from the University of California, Irvine, discuss updated data from the 2023 ESMO Congress on optimal management approaches for gynecologic cancers. CME information and select publications here.Research To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
1:02:43
1:02:43
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:02:43
Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
1:01:22
1:01:22
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:22
Dr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
1:03:45
1:03:45
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:03:45
Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications hereResearch To Practice
…
continue reading
1
Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
1:00:54
1:00:54
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:00:54
Dr Nikhil Khushalani from the Moffitt Cancer Center in Tampa, Florida, and Dr Anna Pavlick from the Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss available and novel treatment strategies for cutaneous squamous cell carcinoma and basal cell carcinoma. CME information and select publications here…
…
continue reading
1
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
1:02:54
1:02:54
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:02:54
Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications hereResearch To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
1:01:37
1:01:37
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:37
Dr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging optimal management approaches for patients with acute myeloid leukemia and myelodysplastic syndromes. CME information and select publications hereResearch To Practice
…
continue reading
1
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
1:01:25
1:01:25
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:25
Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma. CME information and select publications hereResearch To Practice
…
continue reading
1
Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
1:19:38
1:19:38
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:19:38
Dr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent updates and future directions in the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications hereResearch To Practice
…
continue reading
1
Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:32
1:01:32
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:32
Dr Jamie Chaft and Dr John Heymach discuss the optimal integration of targeted therapy and immunotherapy into the care of patients with localized non-small cell lung cancer. CME information and select publications hereResearch To Practice
…
continue reading
Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent updates on available and novel treatment strategies for pancreatic cancer. CME information and select publications hereResearch To Practice
…
continue reading
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. CME information and select publications hereResearch To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
1:02:02
1:02:02
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:02:02
Dr Kathleen Moore from OU Health Stephenson Cancer Center in Oklahoma City discusses treatment decision-making for real-world cases and approved and investigational treatment strategies for the management of ovarian cancer. CME information and select publications hereResearch To Practice
…
continue reading
1
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
47:30
Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications hereResearch To Practice
…
continue reading
1
Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
1:05:15
1:05:15
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:05:15
Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in Santa Monica, California, discuss the current management and actual cases of relapsed/refractory metastatic colorectal cancer moderated by Dr Neil Love. Produced by Research To Practice. CME i…
…
continue reading
Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management approaches for blastic plasmacytoid dendritic cell neoplasms moderated by Dr Neil Love. CME information and select publications hereResearch To Practice
…
continue reading
1
Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
1:04:48
1:04:48
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:04:48
Dr Hope Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Tiffany Traina from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging optimal management approaches for metastatic triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To …
…
continue reading
1
Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
39:10
Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here…
…
continue reading
Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications hereResearch To Practice
…
continue reading
1
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
1:02:43
1:02:43
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:02:43
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chro…
…
continue reading
1
Optimizing the Management of Metastatic Pancreatic Cancer
1:03:48
1:03:48
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:03:48
Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications…
…
continue reading
1
The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
1:00:41
1:00:41
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:00:41
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma moderated by Dr Neil Love. Produced by Re…
…
continue reading
1
Meet The Professor: Optimizing the Management of Melanoma
1:03:01
1:03:01
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:03:01
Prof Georgina Long from the University of Sydney in Sydney, New South Wales, Australia, discusses optimizing the management of melanoma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications hereResearch To Practice
…
continue reading
1
Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
2:43:37
2:43:37
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
2:43:37
Dr Corey Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands discuss the optimal current management of relapsed NSCLC and provide perspectives on the future of care for patients with this disease, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here…
…
continue reading
1
The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
1:02:04
1:02:04
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:02:04
Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publica…
…
continue reading
1
Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
1:01:00
1:01:00
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:00
Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME i…
…
continue reading
Featuring a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr Michael Wang, moderated by Dr Neil Love. CME information and select publications here.Research To Practice
…
continue reading
1
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
1:01:53
1:01:53
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:01:53
Dr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, moderated by Dr Neil Love. CME information and select publications here.Research To Practice
…
continue reading
1
Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
36:05
Dr Jeremy Abramson from Massachusetts General Hospital in Boston discusses key presentations on chronic lymphocytic leukemia and lymphomas from recent oncology/hematology conferences. CME information and select publications hereResearch To Practice
…
continue reading